Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026)

Emergent BioSolutions has reported Treasury Shares for 15 years, with the latest figure at $270.5 million in Q2 2026.

• On a quarterly basis, Treasury Shares rose 15.3% year-over-year to $270.5 million in Q2 2026; TTM through Jun 2026 was $270.5 million, a 15.3% increase from a year earlier, with the FY2025 full-year figure at $252.6 million, up 10.94% from the prior year.
• Treasury Shares was $270.5 million for Q2 2026 at Emergent BioSolutions, up from $261.6 million in the prior quarter.
• The five-year high for Treasury Shares was $10.7 million in Q2 2026, with the low at $4.9 million in Q1 2022.
• Average Treasury Shares over 5 years is $6.4 million, with a median of $5.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares jumped 475.0% in 2022, then changed 0.0% in 2023.
• Over 5 years, Treasury Shares stood at $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then climbed by 10.94% to $252.6 million in 2025, then grew by 7.09% to $270.5 million in 2026.
• The last three Treasury Shares figures came in at $270.5 million (Q2 2026), $261.6 million (Q1 2026), and $252.6 million (Q4 2025), per Business Quant data.